Related Experiment Video
Updated: May 9, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Risk of a recurrent cardiovascular event in individuals with type 2 diabetes or intermediate hyperglycemia: the Hoorn
Amber A W A van der Heijden1, Esther Van't Riet, Sandra D M Bot
1Corresponding author: Amber A.W.A. van der Heijden, a.vanderheijden@vumc.nl.
Insights
Individuals with type 2 diabetes face a higher risk of recurrent cardiovascular events. Early identification of at-risk patients using pre-event profiles is crucial for managing cardiovascular disease.
Area of Science:
- Cardiology
- Endocrinology
- Epidemiology
Background:
- Cardiovascular disease (CVD) poses a significant health burden.
- Understanding risk factors for recurrent CVD events is critical for patient management.
- Glucose metabolism plays a role in cardiovascular health.
Purpose of the Study:
- To determine the risk of recurrent cardiovascular events in a population-based cohort.
- To identify predictors of recurrent cardiovascular events.
- To compare event risk across different glucose metabolism statuses.
Main Methods:
- Prospective follow-up of 336 individuals with a first cardiovascular event (Hoorn Study).
- Calculation of absolute risk for recurrent events based on glucose metabolism (normal, intermediate hyperglycemia, type 2 diabetes).
- Cox regression models used to identify predictors of recurrent events.
Main Results:
- 44% of participants experienced a recurrent vascular event during a median 4.1-year follow-up.
- Recurrent event rates per 100 person-years were 7.2 (normal glucose), 9.8 (intermediate hyperglycemia), and 12.5 (type 2 diabetes).
- Predictors included higher age, male sex, waist circumference, systolic blood pressure, HbA1c, and family history of myocardial infarction.
Conclusions:
- Type 2 diabetes is associated with an increased risk of recurrent vascular events compared to normal glucose metabolism.
- Intermediate hyperglycemia did not show a statistically significant increased risk.
- Patient risk profiles established before the first event can identify individuals at higher risk for recurrence.
Objective:
To investigate risk of a recurrent cardiovascular event and its predictors in a population-based cohort.
Research Design And Methods:
Participants of the Hoorn Study who had experienced a first cardiovascular event after baseline (n = 336) were followed with respect to a recurrent event. Absolute risk of a recurrent event was calculated for individuals with normal glucose metabolism, intermediate hyperglycemia, and type 2 diabetes. Cox regression models were used to investigate which variables, measured before the first vascular event, predicted a recurrent event using the stepwise backward procedure.
Results:
During a median follow-up of 4.1 years, 44% (n = 148) of the population developed a recurrent vascular event. The rate of recurrent events per 100 person-years was 7.2 (95% CI 5.8-8.7) in individuals with normal glucose metabolism, compared with 9.8 (6.6-14.0) in individuals with intermediate hyperglycemia and 12.5 (8.5-17.6) in individuals with type 2 diabetes. Higher age (hazard ratio 1.02 [95% CI 1.00-1.04]), male sex (1.56 [1.08-2.25]), waist circumference (1.02 [1.02-1.03]), higher systolic blood pressure (1.01 [1.01-1.02]), higher HbA1c (%, 1.13 [0.97-1.31]/ mmol/mol, 1.01 [1.00-1.03]), and family history of myocardial infarction (1.38 [0.96-2.00]) predicted a recurrent cardiovascular event.
Conclusions:
Individuals with type 2 diabetes, but not individuals with intermediate hyperglycemia, are at increased risk for a recurrent vascular event compared with individuals with normal glucose metabolism. In people with a history of cardiovascular disease, people at increased risk of a recurrent event can be identified based on the patient's risk profile before the first event.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology
Diabetic Retinopathy
Type II Diabetes I: Introduction
